Learn more about Recursion, the company behind this role.
Open Roles
Manager, Computational Biology (Early Oncology)
Your work will change lives. Including your own. The Impact You’ll Make As a Manager within Recursion's partnership-facing data science team, you will be at the forefront of reimagining drug discovery from first principles. You will lead a team of world-class computational biologists focused on identifying and advancing the next generation of oncology therapeutics. You will act as a "player-coach," balancing direct technical contribution with the mentorship and strategic leadership of a high-performing team. Your mission is to integrate Recursion’s massive datasets—phenomics, transcriptomics, and proteomics—to nominate novel targets, validate disease biology, and define the precision oncology strategies that ensure our medicines reach the right patients. In this role, you will: - Lead and Develop: Direct and mentor a team of data scientists and computational biologists, fostering a culture of scientific rigor, bold experimentation, and continuous professional growth. - Drive Target Discovery: Lead the design and execution of analyses for target nomination and validation, using Recursion’s platform to identify novel vulnerabilities in cancer biology. - Define Early Patient Population Strategy: Develop biomarker strategies and patient-stratification hypotheses to support programs as they progress from nomination through hit-to-lead and lead-optimization. - Bridge the Gap: Act as a key "connector," leading your team to pilot innovative analysis methods and collaborating with platform and engineering teams to productionalize and scale these tools for organization-wide impact. - Execute Hands-On: Maintain a 50% individual contribution (IC) load, performing complex data integration and analysis to solve "killer questions" within the oncology portfolio. - Collaborate Cross-Functionally: Partner with biologists, medicinal chemists, and clinical leads to build compelling data packages that drive program milestones and investment decisions. - Present data analysis to external decision makers and stakeholders in a clear and compelling way that drives toward getting medicines to patients. The Team You’ll Join Our group is a bold, agile, diverse collective of computational drug discovery scientists deeply focused on the singular goal of bringing new therapeutics into the clinic at an accelerated pace. We are a computational group that spans precision oncology, I&I (immunology and inflammation), and neuroscience and focuses on advancing novel, targeted therapies for these disease areas. We partner closely with our biologists and medicinal chemists to design and execute impactful and decisional data analysis for multiple programs. We are responsible for data strategy across the portfolio and supported by computational leadership in designing scalable and reproducible experiments that serve to advance multiple programs within the portfolio. Our team collaborates extensively with computational biologists in other therapeutic areas (neurobiology, immunology, etc.) as well as data scientists and engineers from our core platform teams to provide a strong network of feedback and support. The Experience You
Don't see what you're looking for?
Your work will change lives. Including your own. Join our Talent Network! We believe in the power of hiring because the potential for people to do outstanding work depends on being in the right role, on the right team, at the right time. If you are interested in joining Recursion but don't see the opportunity you'd like to apply for, please send us your resume. We'll keep your information on file and contact you if we find a match! Stay connected and learn more about us on Twitter and LinkedIn. LI-DNI The Values We Hope You Share: - We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust. - We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action. - We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection. - We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day. - We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together. - We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities. Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively. More About Recursion Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting. Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn
Company Details
Registered Agents
No registered agents are associated with this company yet.